NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 4,970 shares of NeueHealth stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares of the company’s stock, valued at $130,085.51. The trade was a 21.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
NeueHealth Price Performance
NeueHealth stock opened at $7.45 on Thursday. The stock has a market cap of $61.72 million, a price-to-earnings ratio of -0.15 and a beta of 0.57. The firm has a 50-day moving average of $5.51 and a two-hundred day moving average of $5.39. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59.
Hedge Funds Weigh In On NeueHealth
A number of hedge funds and other institutional investors have recently modified their holdings of NEUE. Deer Management Co. LLC bought a new position in shares of NeueHealth during the 2nd quarter worth approximately $5,436,000. NEA Management Company LLC acquired a new position in shares of NeueHealth during the second quarter worth $14,834,000. Renaissance Technologies LLC purchased a new stake in shares of NeueHealth during the 2nd quarter valued at $312,000. Finally, Partners Group Holding AG acquired a new stake in shares of NeueHealth in the 3rd quarter worth $463,000. 63.88% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on NeueHealth
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
See Also
- Five stocks we like better than NeueHealth
- Pros And Cons Of Monthly Dividend Stocks
- Breaking the Mold: 3 Non-Tech Stocks Ready to Surge in 2025
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Your Best Trading Year Starts Here: Top 3 Stocks for 2025 Gains
- Election Stocks: How Elections Affect the Stock Market
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.